Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
Nature Medicine2012Vol. 18(2), pp. 221–223
Citations Over TimeTop 1% of 2012 papers
Clara Montagut, Alba Dalmases, Beatríz Bellosillo, Marta Crespo, Silvia Pairet, Mar Iglesias, Marta Salido, Manuel Gallén, Scot A. Marsters, Siao Ping Tsai, André E. Minoche, Somasekar Seshagiri, Sergi Serrano, Heinz Himmelbauer, Joaquim Bellmunt, Ana Rovira, Jeff Settleman, Francesc Bosch, Joan Albanell
Related Papers
- → Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer(2006)110 cited
- → Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII(2007)35 cited
- → Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines(2017)18 cited
- → Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab(2016)2 cited
- Cetuximab in Patients with Non-Small Cell Lung Cancer and EGFR Exon 20 Insertion Alterations.(2022)